14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.02 $17.49 Wednesday, 24th Apr 2024 CRIS stock ended at $14.77. This is 1.60% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.07% from a day low at $14.71 to a day high of $15.01.
90 days $8.24 $17.49
52 weeks $0.380 $17.49

Historical Curis prices

Date Open High Low Close Volume
Feb 12, 2024 $10.51 $11.25 $10.51 $10.72 18 701
Feb 09, 2024 $10.33 $10.51 $9.88 $10.41 14 699
Feb 08, 2024 $9.75 $10.65 $9.29 $10.65 103 130
Feb 07, 2024 $9.47 $9.62 $9.17 $9.39 18 222
Feb 06, 2024 $8.49 $9.53 $8.49 $9.42 72 648
Feb 05, 2024 $9.91 $10.28 $8.24 $8.49 96 564
Feb 02, 2024 $10.20 $10.44 $10.03 $10.25 22 169
Feb 01, 2024 $9.93 $10.36 $9.93 $10.20 25 514
Jan 31, 2024 $10.00 $10.24 $9.69 $9.90 115 474
Jan 30, 2024 $9.52 $10.22 $9.52 $10.00 83 934
Jan 29, 2024 $10.10 $10.21 $9.54 $9.54 13 608
Jan 26, 2024 $9.64 $10.36 $9.57 $10.29 27 955
Jan 25, 2024 $9.26 $9.70 $9.15 $9.64 32 384
Jan 24, 2024 $11.52 $11.66 $9.06 $9.10 169 463
Jan 23, 2024 $11.63 $11.66 $11.30 $11.32 10 954
Jan 22, 2024 $11.75 $11.80 $11.34 $11.34 10 796
Jan 19, 2024 $12.33 $12.33 $11.20 $11.62 32 894
Jan 18, 2024 $12.72 $12.72 $12.02 $12.24 17 258
Jan 17, 2024 $11.83 $12.78 $11.73 $12.78 21 192
Jan 16, 2024 $12.61 $12.77 $11.49 $11.70 68 478
Jan 12, 2024 $13.16 $13.24 $12.61 $12.80 14 078
Jan 11, 2024 $13.15 $13.40 $12.78 $13.01 14 453
Jan 10, 2024 $13.75 $13.75 $13.10 $13.25 12 659
Jan 09, 2024 $13.01 $13.74 $13.01 $13.71 23 042
Jan 08, 2024 $12.61 $13.90 $12.44 $13.50 38 802
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT